Carregant...

Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines

Advanced small cell lung cancer (SCLC) has a dismal prognosis. Modulation of the camptothecin topotecan, approved for second-line therapy, may improve response. Our recent finding of synergistic enhancement of the cytotoxic activity of camptothecin (CPT) by cyclin-dependent kinase 4 inhibitors is ex...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Molecules
Autors principals: Hamilton, Gerhard, Klameth, Lukas, Rath, Barbara, Thalhammer, Theresia
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6271949/
https://ncbi.nlm.nih.gov/pubmed/24549232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules19022077
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!